Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 3, 2014, Pages 297-304

  Ishiyama, Hiromichi ^a,d   Hirayama, Takahiro ^b,d   Jhaveri, Pavan ^c   Satoh, Takefumi ^d   Paulino, Arnold C ^a   Xu, Bo ^a   Butler, Edward Brian ^a   Teh, Bin S ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genitourinary toxicity; Prostate cancer; Radiotherapy; Turp

Indexed keywords

BLADDER DISEASE; BLADDER NECK STRICTURE; CANCER RADIOTHERAPY; CANCER SURGERY; COCHRANE LIBRARY; EMBASE; GENITOURINARY TOXICITY; HUMAN; INTERMETHOD COMPARISON; MALE; MEDLINE; NONHUMAN; PROSTATE CANCER; RADIATION INJURY; REVIEW; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; URINE INCONTINENCE; ADJUVANT THERAPY; BRACHYTHERAPY; INJURY; LOW LEVEL LASER THERAPY; METHODOLOGY; MICTURITION DISORDER; PATHOLOGY; PROSTATE HYPERTROPHY; PROSTATE TUMOR; RADIATION EXPOSURE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STENOSIS, OCCLUSION AND OBSTRUCTION; TIME; URETHRA; UROGENITAL SYSTEM;

BRACHYTHERAPY; CONSTRICTION, PATHOLOGIC; HUMANS; LASER THERAPY; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; URETHRA; URINATION DISORDERS; UROGENITAL SYSTEM;

EID: 84904017001     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182546821     Document Type: Review

References (59)

1. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med. 1995;332:75-79.
2. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
3. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:332-336, b2535.
4. Devisetty K, Zorn KC, Katz MH, et al. External beam radiation therapy after transurethral resection of the prostate: A report on acute and late genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2010;77:1060-1065.
5. Ghadjar P, Gwerder N, Manser P, et al. High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer. Strahlenther Onkol. 2010;186:687-692.
6. Choe KS, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys. 2010;76:755-760.
7. Luo HL, Fang FM, Chuang YC, et al. Previous transurethral resection of the prostate is not a contraindication to high-dose rate brachytherapy for prostate cancer. BJU Int. 2009;104:1620-1623.
8. Nakamura RA, Monti CR, Castilho LN, et al. Prognostic factors for late urinary toxicity grade 2-3 after conformal radiation therapy on patients with prostate cancer. Int Braz J Urol. 2007;33: 652-659; discussion 660-651.
9. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005;61:1306-1316.
10. Peeters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005;61:1019-1034.
11. Merrick GS, Butler WM, Wallner KE, et al. Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004;58:81-88.
12. Liu M, Pickles T, Agranovich A, et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 58:59-67.
13. Sandhu AS, Zelefsky MJ, Lee HJ, et al. Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection. Int J Radiat Oncol Biol Phys. 2000;48:643-647.
14. Schultheiss TE, Lee WR, Hunt MA, et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:3-11.
15. Zelefsky MJ, Whitmore WF Jr. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol. 1997;158:23-29; discussion 29-30.
16. Liu M, Pickles T, Berthelet E, et al. Urinary incontinence in prostate cancer patients treated with external beam radiotherapy. Radiother Oncol. 2005;74:197-201.
17. Galalae RM, Kovacs G, Schultze J, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys. 2002;52:81-90.
18. Talcott JA, Clark JA, Stark PC, et al. Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated. J Urol. 2001;166:494-499.
19. Ragde H, Blasko JC, Grimm PD, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer. 1997;80:442-453.
20. Lee WR, Schultheiss TE, Hanlon AL, et al. Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer. Urology. 1996;48:95-99.
21. Jonler M, Ritter MA, Brinkmann R, et al. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urology. 1994;44:876-882.
22. Zelefsky MJ, Whitmore WF Jr., Leibel SA, et al. Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma. J Urol. 1993;150:1860-1864.
23. Blasko JC, Ragde H, Grimm PD. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications. Scand J Urol Nephrol Suppl. 1991;137:113-118.
24. Green N, Treible D, Wallack H. Prostate cancer: post-irradiation incontinence. J Urol. 1990;144:307-309.
25. Amdur RJ, Parsons JT, Fitzgerald LT, et al. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up. Radiother Oncol. 1990;18:235-246.
26. Pilepich MV, Perez CA, Walz BJ, et al. Complications of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1981;7:1341-1348.
27. Perez CA, Walz BJ, Zivnuska FR, et al. Irradiation of carcinoma of the prostate localized to the pelvis: Analysis of tumor response and prognosis. Int J Radiat Oncol Biol Phys. 1980;6:555-563.
28. Gibbons RP, Mason JT, Correa RJ Jr., et al. Carcinoma of the prostate: local control with external beam radiation therapy. J Urol. 1979;121:310-312.
29. Heemsbergen WD, Al-Mamgani A, Witte MG, et al. Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics. Int J Radiat Oncol Biol Phys. 2010;78:19-25.
30. Sullivan L, Williams SG, Tai KH, et al. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol. 2009;91:232-236.
31. Perez CA, Lee HK, Georgiou A, et al. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1994;28:811-819.
32. Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 1991;21:935-939.
33. Shipley WU, Prout GR Jr., Coachman NM, et al. Radiation therapy for localized prostate carcinoma: experience at the Massachusetts General Hospital (1973-1981). NCI Monogr. 1988;7:67-73.
34. Seymore CH, el-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys. 1986;12:1597-1600.
35. Wallner K, Lee H, Wasserman S, et al. Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection. Int J Radiat Oncol Biol Phys. 1997;37:565-569.
36. Stone NN, Ratnow ER, Stock RG. Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation. Tech Urol. 2000;6:123-127.
37. Warres HL. Urethral stricture following transurethral resection of the prostate. J Urol. 1958;79:989-993.
38. Hamm FC, Weinberg SR. Experimental studies of regeneration of the ureter without intubation. J Urol. 1956;75:43-51.
39. Weaver RG. Ureteral regeneration: experimental and clinical. II. J Urol. 1957;77:164-172.
40. Weaver RG, Schulte JW. Experimental and clinical studies of urethral regeneration. Surg Gynecol Obstet. 1962;115:729-736.
41. Antonakopoulos GN, Hicks RM, Hamilton E, et al. Early and late morphological changes (including carcinoma of the urothelium) induced by irradiation of the rat urinary bladder. Br J Cancer. 1982;46:403-416.
42. Antonakopoulos GN, Hicks RM, Berry RJ. The subcellular basis of damage to the human urinary bladder induced by irradiation. J Pathol. 1984;143:103-116.
43. Marks LB, Carroll PR, Dugan TC, et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31:1257-1280.
44. Stewart FA. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl. 1986;7:280-291.
45. Petraki CD, Sfikas CP. Histopathological changes induced by therapies in the benign prostate and prostate adenocarcinoma. Histol Histopathol. 2007;22:107-118.
46. Kollmeier MA, Stock RG, Cesaretti J, et al. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol. 2005;173:808-812.
47. Hirshberg ED, Klotz LH. Post transurethral resection of prostate incontinence in previously radiated prostate cancer patients. Can J Urol. 1998;5:560-563.
48. Flam TA, Peyromaure M, Chauveinc L, et al. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol. 2004;172:108-111.
49. Hu K, Wallner K. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;40:783-786.
50. Koutrouvelis PG, Lailas N, Goldson A, et al. Three dimentional computed tomography-guided ischiorectal brachytherapy of prostate cancer in patients with prior transurethral resection of the prostate. J Brachyther Int. 1999;15:65-72.
51. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789-799.
52. Neal DE. The National Prostatectomy Audit. Br J Urol. 1997;79(suppl 2):69-75.
53. Harkaway RC, Issa MM. Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2006;9:204-214.
54. Riehmann M, Knes JM, Heisey D, et al. Transurethral resection versus incision of the prostate: A randomized, prospective study. Urology. 1995;45:768-775.
55. Jahnson S, Dalen M, Gustavsson G, et al. Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol. 1998;81:276-281.
56. Hoffman RM, MacDonald R, Wilt TJ. Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev. 2004;CD001987.
57. Poulakis V, Dahm P, Witzsch U, et al. Transurethral electrovaporization vs transurethral resection for symptomatic prostatic obstruction: A meta-analysis. BJU Int. 2004;94:89-95.
58. Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol. 2004;171:2336-2340.
59. Hoffman RM, MacDonald R, Monga M, et al. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: A systematic review. BJU Int. 2004;94:1031-1036.